Clinical Trial Update: Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on enteric-coated mycophenolate sodium (EC-MPS) assessing efficacy and safety in de novo kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Drugs mentioned

• Enteric-coated mycophenolate sodium (mycophenolate sodium)

Snippet

Sponsor: Zhishui Chen | Conditions: Kidney Transplant Rejection | Phase 4 | Status: UNKNOWN